Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, September 10, 2020
Presage Biosciences announced a new research collaboration with Takeda that will utilize CIVO to evaluate multiple investigational oncology agents and combinations in Phase 0 trials.
read more
Thursday, September 10, 2020
Sygnature Discovery has appointed Dr. Andy Mead as Director and Head of Drug Abuse and Substance Use Disorders at its integrated in vivo pharmacology company, RenaSci.
read more
Thursday, September 10, 2020
NKMax America has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer to evaluate the safety and tolerability of SNK01.
read more
Thursday, September 10, 2020
Exelixis and Catalent announced a partnership under which Catalent’s Redwood Bioscience subsidiary will develop multiple ADCs for Exelixis using Catalent’s proprietary SMARTag site-specific bioconjugation technology.
read more
Friday, September 11, 2020
REGENXBIO has dosed the first patient in its trial to evaluate the suprachoroidal delivery of RGX-314 using Clearside’s SCS Microinjector for the treatment of wet AMD.
read more
Friday, September 11, 2020
Catalent is investing $130 million to add five additional Phase 3 through commercial-scale manufacturing suites to its gene therapy campus in Maryland.
read more
Friday, September 11, 2020
Direct Biologics will leverage Bioclinica's Interactive Response Technology (IRT) for their EXIT COVID-19 study.
read more
Friday, September 11, 2020
The companies will work together on the advancement and commercial scale-up of Evonetix’s proprietary MEMS-based silicon chips and accelerate the development of Evonetix’s first product, a DNA desktop writer.
read more
Monday, September 14, 2020
MilliporeSigma announced a $65 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin.
read more
Monday, September 14, 2020
Rockwell Medical has entered into an exclusive license agreement with Jeil for the rights to commercialize Triferic in South Korea.
read more
Monday, September 14, 2020
Valneva announced the signing of a new contract, lasting up to three years, with the U.S. government DoD for the supply of its Japanese encephalitis vaccine IXIARO.
read more
Monday, September 14, 2020
KVK has entered a collaboration agreement with Sure Med, a mission-based organization focused on supporting physicians in combating the opioid epidemic through greater prescribing education and compliance.
read more
Monday, September 14, 2020
Kraton is seeking regulatory approval for BIAXAM, a novel sulfonated polymer technology with long-lasting self-disinfecting properties.
read more
Monday, September 14, 2020
Thermo Fisher Scientific has announced the opening of its new Bioprocessing Collaboration Center in St. Louis, Missouri.
read more
Tuesday, September 15, 2020
The two organizations form an agile and scalable consulting firm dedicated to their combined focus areas in the life science industry.
read more